Actively Recruiting
Stellate Ganglion Block in Complex Regional Pain Syndrome
Led by Ankara City Hospital Bilkent · Updated on 2025-09-05
32
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.
CONDITIONS
Official Title
Stellate Ganglion Block in Complex Regional Pain Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Volunteer male and female patients aged 18-75
- Diagnosed with Complex Regional Pain Syndrome according to the IASP 2012 Diagnostic Criteria
- Patient's pain level must be VAS >4
You will not qualify if you...
- Presence of existing neurological diseases other than rheumatic diseases and stroke
- General impairment
- Conditions that would constitute a contraindication to application, such as an open wound or sensory deficit in the application area
- Presence of active infection
- Presence of malignancy
- Cognitive dysfunction (mini mental test result <23)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara Bilkent City Hospital
Ankara, Çankaya, Turkey (Türkiye)
Actively Recruiting
Research Team
S
Seher KALIÇ MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here